Health Catalyst (HCAT) Misses Q1 EPS by 22c, Offers Q2 Guidance
Get Alerts HCAT Hot Sheet
Join SI Premium – FREE
Health Catalyst (NASDAQ: HCAT) reported Q1 EPS of ($0.47), $0.22 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $45.1 million versus the consensus estimate of $43.47 million.
Financial Outlook:
Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.
For the second-quarter of 2020, we expect:
- Total revenue between $40.8 million and $43.8 million, and
- Adjusted EBITDA between $(7.8) million and $(5.8) million
(Consensus calls for Q2 revenue of $43.3 million)
For earnings history and earnings-related data on Health Catalyst (HCAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) Tops Q1 EPS by 6c, Misses on Revenue; Offers Guidance
- Wintrust Financial (WTFC) Tops Q1 EPS by 49c
- Liberty Oilfield Services (LBRT) Misses Q1 EPS by 6c, provides outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!